Genetic Association Analysis of Functional Polymorphisms in Neuronal Nitric Oxide Synthase 1 Gene (NOS1) and Mood Disorders and Fluvoxamine Response in Major Depressive Disorder in the Japanese Population

被引:23
作者
Okumura, Takenori [1 ]
Kishi, Taro [1 ]
Okochi, Tomo [1 ]
Ikeda, Masashi [1 ,4 ]
Kitajima, Tsuyoshi [1 ]
Yamanouchi, Yoshio [1 ]
Kinoshita, Yoko [1 ]
Kawashima, Kunihiro [1 ]
Tsunoka, Tomoko [1 ]
Inada, Toshiya [3 ]
Ozaki, Norio [2 ]
Iwata, Nakao [1 ]
机构
[1] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 47011, Japan
[2] Nagoya Univ, Dept Psychiat, Grad Sch Med, Nagoya, Aichi 4648601, Japan
[3] Seiwa Hosp, Neuropsychiat Res Inst, Tokyo, Japan
[4] Cardiff Univ, Sch Med, Dept Psychol Med, Cardiff, S Glam, Wales
关键词
Bipolar disorder; Major depressive disorder; Fluvoxamine; Neuronal nitric oxide synthase 1 gene; Functional single nucleotide polymorphisms; STRESS-INDUCED DEPRESSION; SEX-DIFFERENCES; SCHIZOPHRENIA; METABOLITES; HAPLOTYPE; PATHWAY; LINKAGE; MODELS;
D O I
10.1159/000265130
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background/Aim: Nitric oxide has been reported to play a role in neural transmitter release and N-methyl-D-aspartate receptor activation, as well as to be related to oxidative stress. Abnormalities in both of these mechanisms are thought to be involved in the pathophysiology of mood disorders including major depressive disorder (MDD) and bipolar disorder (BP). In addition, several lines of evidence support an association between abnormalities in neuronal nitric oxide synthases (nNOS) and mood disorders. Therefore, we studied the association of nNOS gene (NOS1) and mood disorders and the efficacy of fluvoxamine treatment in Japanese MDD patients. Materials and Methods: Using a single nucleotide polymorphism (SNP; rs41279104, also called ex1c), we conducted a genetic association analysis of case-control samples (325 MDD patients, 154 BP patients and 807 controls) in the Japanese population. In addition, we performed an association analysis between NOS1 and the efficacy of fluvoxamine treatment in 117 MDD patients. We defined a clinical response as a decrease of more than 50% in baseline SIGH-D (Structured Interview Guide for the Hamilton Rating Scale for Depression) score within 8 weeks, and clinical remission as an SIGH-D score of less than 7 at 8 weeks. Results: We did not detect a significant association between NOS1 and MDD, BP or the fluvoxamine therapeutic response in MDD in allele/genotype-wise analysis. Conclusions: We did not detect an association between only one marker (rs41279104) in NOS1 and Japanese mood disorder patients and fluvoxamine response, but sample sizes were probably too small to allow a meaningful test. Moreover, because we did not perform an association analysis based on linkage disequilibrium and a mutation scan of NOS1, a replication of the study using a larger sample and based on linkage disequilibrium may be required for conclusive results. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:57 / 63
页数:7
相关论文
共 48 条
[1]  
Akyol O, 2004, IN VIVO, V18, P377
[2]   GENETIC MODELS OF SEX EFFECT IN UNIPOLAR AFFECTIVE-ILLNESS [J].
BARON, M .
ACTA PSYCHIATRICA SCANDINAVICA, 1981, 64 (01) :85-91
[3]   Further immunohistochemical evidence for impaired NO signaling in the hypothalamus of depressed patients [J].
Bernstein, HG ;
Heinemann, A ;
Krell, D ;
Mawrin, C ;
Bielau, H ;
Danos, P ;
Diekmann, S ;
Keilhoff, G ;
Bogerts, B ;
Baumann, B .
CELL SIGNALING, TRANSCRIPTION, AND TRANSLATION AS THERAPEUTIC TARGETS, 2002, 973 :91-93
[4]   Genetic studies of bipolar affective disorder in large families [J].
Blackwood, DHR ;
Visscher, PM ;
Muir, WJ .
BRITISH JOURNAL OF PSYCHIATRY, 2001, 178 :S134-S136
[5]   Nitric oxide donors inhibit 5-hydroxytryptamine (5-HT) uptake by the human 5-HT transporter (SERT) [J].
Bryan-Lluka, LJ ;
Papacostas, MH ;
Paczkowski, FA ;
Wanstall, JC .
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 143 (01) :63-70
[6]   No association between a neuronal nitric oxide synthase (NOS1) gene polymorphism on chromosome 12q24 and bipolar disorder [J].
Buttenschön, HN ;
Mors, O ;
Ewald, H ;
McQuillin, A ;
Kalsi, G ;
Lawrence, J ;
Gurling, H ;
Kruse, TA .
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2004, 124B (01) :73-75
[7]   Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder [J].
Chrapko, WE ;
Jurasz, P ;
Radomski, MW ;
Lara, N ;
Archer, SL ;
Le Mellédo, JM .
BIOLOGICAL PSYCHIATRY, 2004, 56 (02) :129-134
[8]   Genetics of bipolar disorder: successful start to a long journey [J].
Craddock, Nick ;
Sklar, Pamela .
TRENDS IN GENETICS, 2009, 25 (02) :99-105
[9]   Sex differences in the familial transmission of mood disorders [J].
Currier, Dianne ;
Mann, Mark J. ;
Oquendo, Maria A. ;
Galfalvy, Hanga ;
Mann, John J. .
JOURNAL OF AFFECTIVE DISORDERS, 2006, 95 (1-3) :51-60
[10]   Bipolar I disorder and schizophrenia: A 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios [J].
Fallin, MD ;
Lasseter, VK ;
Avramopoulos, D ;
Nicodemus, KK ;
Wolyniec, PS ;
McGrath, JA ;
Steel, G ;
Nestadt, G ;
Liang, KY ;
Huganir, RL ;
Valle, D ;
Pulver, AE .
AMERICAN JOURNAL OF HUMAN GENETICS, 2005, 77 (06) :918-936